ReviewLancet (London, England)2017
China's Silk Road and global health.
Review in Lancet (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Barriers to Community-Based Primary Health Care Delivery in Urban China: A Systematic Mapping Review.International journal of environmental research and public health · 2022Pooled it
- Japan's global health engagement in the Western Pacific: diagnosing structural inertia and a framework for human security diplomacy.The Lancet regional health. Western Pacific · 2026Review
- Application of patient-reported outcomes in clinical trials of traditional Chinese medicine registered in international clinical trials registry platform, from 2010 to 2022: a cross-sectional study.Journal of patient-reported outcomes · 2026Article
- A phytochemical-nanotechnology platform exhibits complementary antimicrobial and immunomodulatory effects in experimental fowl typhoid.Frontiers in microbiology · 2026Article
- Thalassemia in Guangxi: current situation and future prospects.Frontiers in public health · 2026Article
- Differences in the burden and temporal trend of stroke in the Belt and Road Initiative countries, 1990-2021.Open medicine (Warsaw, Poland) · 2026Article
- Global, regional and national burden of epilepsy in adolescents aged 10-19 years from 1990 to 2021: An analysis for the Global Burden of Disease Study 2021.Epilepsia open · 2025Article
- China's COVID-19 aid in Africa: trends and implications for future pandemic preparedness.Globalization and health · 2025Article
- Burden of disease in the Belt and Road countries from 1990 to 2021: analysis of estimates from the Global Burden of Disease 2021.Global health research and policy · 2025Article
- Implications for developing global health education in China: evidence from an undergraduate teamwork with role-play.BMJ global health · 2025Article
- States, global power and access to medicines: a comparative case study of China, India and the United States, 2000-2019.Globalization and health · 2025Article
- Molecular genotyping of multi-system rare blood types in foreign blood donors based on DNA sequencing and its clinical significance.Open medicine (Warsaw, Poland) · 2025Article
- A critical review of Chinese vaccine enterprises in the global aid market: evolution, drivers, and structural constraints.Frontiers in public health · 2025Review
- Trends in disease burden and risk factors of asthma from 1990 to 2019 in Belt and Road Initiative countries: evidence from the Global Burden of Disease Study 2019.Annals of medicine · 2024Article
- Spatial and temporal patterns of disease burden attributable to high BMI in Belt and Road Initiative countries, 1990-2019.Public health nutrition · 2024Article
- Epidemiological variations and trends in glaucoma burden in the Belt and Road countries.BMC ophthalmology · 2024Article
- Understanding China's shifting priorities and priority-setting processes in development assistance for health.Health policy and planning · 2024Article
- HIV/AIDS, SARS, and COVID-19: the trajectory of China's pandemic responses and its changing politics in a contested world.Globalization and health · 2024Review
- China's hidden role in malaria control and elimination in Africa.BMJ global health · 2023Article
- China's application of the One Health approach in addressing public health threats at the human-animal-environment interface: Advances and challenges.One health (Amsterdam, Netherlands) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2013, China proposed its Belt and Road Initiative to promote trade, infrastructure, and commercial associations with 65 countries in Asia, Africa, and Europe. This initiative contains important health components. Simultaneously, China launched an unprecedented overseas intervention against Ebola virus in west Africa, dispatching 1200 workers, including Chinese military personnel. The overseas development assistance provided by China has been increasing by 25% annually, reaching US$7 billion in 2013. Development assistance for health from China has particularly been used to develop infrastructure and provide medical supplies to Africa and Asia. China's contributions to multilateral organisations are increasing but are unlikely to bridge substantial gaps, if any, vacated by other donors; China is creating its own multilateral funds and banks and challenging the existing global architecture. These new investment vehicles are more aligned with the geography and type of support of the Belt and Road Initiative. Our analysis concludes that China's Belt and Road Initiative, Ebola response, development assistance for health, and new investment funds are complementary and reinforcing, with China shaping a unique global engagement impacting powerfully on the contours of global health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.